The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Weight Loss Therapeutics-Global Market Insights and Sales Trends 2024
Synopsis
Currently, available weight loss mainly therapeutics works by appetite suppression, increasing body metabolism and interfering with the digestion and absorption patterns.
The global Weight Loss Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Weight Loss Therapeutics in various end use industries. The expanding demands from the Hospitals, Specialized Clinics, Retail Pharmacies and Mail Order Pharmacies, are propelling Weight Loss Therapeutics market. Appetite Suppression, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Increasing Body Metabolism segment is estimated at % CAGR for the next seven-year period.
According to our Wellness & Health Research Center, the global wellness & health economy was valued at US dollars 4.8 trillion. Asia Pacific was the region with the highest spending on big health in 2022, with a total spending of $1.68 trillion, followed by North America ($1.42 trillion) and Europe ($1.0 trillion). According to the health industry accounting analysis data disclosed by the Health Development Research Center of the National Health Commission, from 2019 to 2021, the market size of the health service industry grew by an average of 7.0% per year, and the specific data increased from 7.7 trillion yuan to 8.8 trillion yuan. China's health industry revenue reached 8.0 trillion yuan in 2021, with an increase of 8.1%. According to public information, in 2022, there were about 1.2 billion obesity cases worldwide, among them, the number of obesity cases in China reached 230 million. Wellness & Health Research Center, the global sports economy was valued at 750 billion in 2022, 92% of global spending on physical activity occurs in Asia Pacific, North America and Europe. And China and the United States accounted for 44% of total sports spending.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Weight Loss Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Weight Loss Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Weight Loss Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Weight Loss Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Weight Loss Therapeutics covered in this report include Abbott, Sanofi, Novo Nordisk, Arena Pharmaceuticals, Orexigen Therapeutics, Johnson & Johnson, Pfizer, Novartis AG and Biocon, etc.
The global Weight Loss Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Sanofi
Novo Nordisk
Arena Pharmaceuticals
Orexigen Therapeutics
Johnson & Johnson
Pfizer
Novartis AG
Biocon
VIVUS
Eli Lilly
Amgen
Zafgen
Roche
Eisai
Global Weight Loss Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Weight Loss Therapeutics market, Segment by Type:
Appetite Suppression
Increasing Body Metabolism
Interfering with the Digestion Absorption Patterns
Global Weight Loss Therapeutics market, by Application
Hospitals
Specialized Clinics
Retail Pharmacies
Mail Order Pharmacies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Weight Loss Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Currently, available weight loss mainly therapeutics works by appetite suppression, increasing body metabolism and interfering with the digestion and absorption patterns.
The global Weight Loss Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Weight Loss Therapeutics in various end use industries. The expanding demands from the Hospitals, Specialized Clinics, Retail Pharmacies and Mail Order Pharmacies, are propelling Weight Loss Therapeutics market. Appetite Suppression, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Increasing Body Metabolism segment is estimated at % CAGR for the next seven-year period.
According to our Wellness & Health Research Center, the global wellness & health economy was valued at US dollars 4.8 trillion. Asia Pacific was the region with the highest spending on big health in 2022, with a total spending of $1.68 trillion, followed by North America ($1.42 trillion) and Europe ($1.0 trillion). According to the health industry accounting analysis data disclosed by the Health Development Research Center of the National Health Commission, from 2019 to 2021, the market size of the health service industry grew by an average of 7.0% per year, and the specific data increased from 7.7 trillion yuan to 8.8 trillion yuan. China's health industry revenue reached 8.0 trillion yuan in 2021, with an increase of 8.1%. According to public information, in 2022, there were about 1.2 billion obesity cases worldwide, among them, the number of obesity cases in China reached 230 million. Wellness & Health Research Center, the global sports economy was valued at 750 billion in 2022, 92% of global spending on physical activity occurs in Asia Pacific, North America and Europe. And China and the United States accounted for 44% of total sports spending.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Weight Loss Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Weight Loss Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Weight Loss Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Weight Loss Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Weight Loss Therapeutics covered in this report include Abbott, Sanofi, Novo Nordisk, Arena Pharmaceuticals, Orexigen Therapeutics, Johnson & Johnson, Pfizer, Novartis AG and Biocon, etc.
The global Weight Loss Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Sanofi
Novo Nordisk
Arena Pharmaceuticals
Orexigen Therapeutics
Johnson & Johnson
Pfizer
Novartis AG
Biocon
VIVUS
Eli Lilly
Amgen
Zafgen
Roche
Eisai
Global Weight Loss Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Weight Loss Therapeutics market, Segment by Type:
Appetite Suppression
Increasing Body Metabolism
Interfering with the Digestion Absorption Patterns
Global Weight Loss Therapeutics market, by Application
Hospitals
Specialized Clinics
Retail Pharmacies
Mail Order Pharmacies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Weight Loss Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Weight Loss Therapeutics
1.1 Weight Loss Therapeutics Market Overview
1.1.1 Weight Loss Therapeutics Product Scope
1.1.2 Weight Loss Therapeutics Market Status and Outlook
1.2 Global Weight Loss Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Weight Loss Therapeutics Market Size by Region (2018-2029)
1.4 Global Weight Loss Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Weight Loss Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Weight Loss Therapeutics Market Size (2018-2029)
1.6.1 North America Weight Loss Therapeutics Market Size (2018-2029)
1.6.2 Europe Weight Loss Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Weight Loss Therapeutics Market Size (2018-2029)
1.6.4 Latin America Weight Loss Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Weight Loss Therapeutics Market Size (2018-2029)
2 Weight Loss Therapeutics Market by Type
2.1 Introduction
2.1.1 Appetite Suppression
2.1.2 Increasing Body Metabolism
2.1.3 Interfering with the Digestion Absorption Patterns
2.2 Global Weight Loss Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Weight Loss Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Weight Loss Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Weight Loss Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Weight Loss Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Weight Loss Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Weight Loss Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Weight Loss Therapeutics Revenue Breakdown by Type (2018-2029)
3 Weight Loss Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Specialized Clinics
3.1.3 Retail Pharmacies
3.1.4 Mail Order Pharmacies
3.1.5 Others
3.2 Global Weight Loss Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Weight Loss Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Weight Loss Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Weight Loss Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Weight Loss Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Weight Loss Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Weight Loss Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Weight Loss Therapeutics Revenue Breakdown by Application (2018-2029)
4 Weight Loss Therapeutics Competition Analysis by Players
4.1 Global Weight Loss Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Weight Loss Therapeutics as of 2022)
4.3 Date of Key Players Enter into Weight Loss Therapeutics Market
4.4 Global Top Players Weight Loss Therapeutics Headquarters and Area Served
4.5 Key Players Weight Loss Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Weight Loss Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Weight Loss Therapeutics Products, Services and Solutions
5.1.4 Abbott Weight Loss Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 Sanofi
5.2.1 Sanofi Profile
5.2.2 Sanofi Main Business
5.2.3 Sanofi Weight Loss Therapeutics Products, Services and Solutions
5.2.4 Sanofi Weight Loss Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Sanofi Recent Developments
5.3 Novo Nordisk
5.3.1 Novo Nordisk Profile
5.3.2 Novo Nordisk Main Business
5.3.3 Novo Nordisk Weight Loss Therapeutics Products, Services and Solutions
5.3.4 Novo Nordisk Weight Loss Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Arena Pharmaceuticals Recent Developments
5.4 Arena Pharmaceuticals
5.4.1 Arena Pharmaceuticals Profile
5.4.2 Arena Pharmaceuticals Main Business
5.4.3 Arena Pharmaceuticals Weight Loss Therapeutics Products, Services and Solutions
5.4.4 Arena Pharmaceuticals Weight Loss Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Arena Pharmaceuticals Recent Developments
5.5 Orexigen Therapeutics
5.5.1 Orexigen Therapeutics Profile
5.5.2 Orexigen Therapeutics Main Business
5.5.3 Orexigen Therapeutics Weight Loss Therapeutics Products, Services and Solutions
5.5.4 Orexigen Therapeutics Weight Loss Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Orexigen Therapeutics Recent Developments
5.6 Johnson & Johnson
5.6.1 Johnson & Johnson Profile
5.6.2 Johnson & Johnson Main Business
5.6.3 Johnson & Johnson Weight Loss Therapeutics Products, Services and Solutions
5.6.4 Johnson & Johnson Weight Loss Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Johnson & Johnson Recent Developments
5.7 Pfizer
5.7.1 Pfizer Profile
5.7.2 Pfizer Main Business
5.7.3 Pfizer Weight Loss Therapeutics Products, Services and Solutions
5.7.4 Pfizer Weight Loss Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Pfizer Recent Developments
5.8 Novartis AG
5.8.1 Novartis AG Profile
5.8.2 Novartis AG Main Business
5.8.3 Novartis AG Weight Loss Therapeutics Products, Services and Solutions
5.8.4 Novartis AG Weight Loss Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Novartis AG Recent Developments
5.9 Biocon
5.9.1 Biocon Profile
5.9.2 Biocon Main Business
5.9.3 Biocon Weight Loss Therapeutics Products, Services and Solutions
5.9.4 Biocon Weight Loss Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Biocon Recent Developments
5.10 VIVUS
5.10.1 VIVUS Profile
5.10.2 VIVUS Main Business
5.10.3 VIVUS Weight Loss Therapeutics Products, Services and Solutions
5.10.4 VIVUS Weight Loss Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 VIVUS Recent Developments
5.11 Eli Lilly
5.11.1 Eli Lilly Profile
5.11.2 Eli Lilly Main Business
5.11.3 Eli Lilly Weight Loss Therapeutics Products, Services and Solutions
5.11.4 Eli Lilly Weight Loss Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 Eli Lilly Recent Developments
5.12 Amgen
5.12.1 Amgen Profile
5.12.2 Amgen Main Business
5.12.3 Amgen Weight Loss Therapeutics Products, Services and Solutions
5.12.4 Amgen Weight Loss Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 Amgen Recent Developments
5.13 Zafgen
5.13.1 Zafgen Profile
5.13.2 Zafgen Main Business
5.13.3 Zafgen Weight Loss Therapeutics Products, Services and Solutions
5.13.4 Zafgen Weight Loss Therapeutics Revenue (US$ Million) & (2018-2023)
5.13.5 Zafgen Recent Developments
5.14 Roche
5.14.1 Roche Profile
5.14.2 Roche Main Business
5.14.3 Roche Weight Loss Therapeutics Products, Services and Solutions
5.14.4 Roche Weight Loss Therapeutics Revenue (US$ Million) & (2018-2023)
5.14.5 Roche Recent Developments
5.15 Eisai
5.15.1 Eisai Profile
5.15.2 Eisai Main Business
5.15.3 Eisai Weight Loss Therapeutics Products, Services and Solutions
5.15.4 Eisai Weight Loss Therapeutics Revenue (US$ Million) & (2018-2023)
5.15.5 Eisai Recent Developments
6 North America
6.1 North America Weight Loss Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Weight Loss Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Weight Loss Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Weight Loss Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Weight Loss Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Weight Loss Therapeutics Market Dynamics
11.1 Weight Loss Therapeutics Industry Trends
11.2 Weight Loss Therapeutics Market Drivers
11.3 Weight Loss Therapeutics Market Challenges
11.4 Weight Loss Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
